Deputy Director, The George Institute UK
- Associate Professor of Cardiovascular Medicine
- James Martin Senior Fellow in Essential Healthcare at the University of Oxford
- Honorary Consultant Cardiologist at the John Radcliffe Hospital, Oxford
Prof Kazem Rahimi is a cardiologist with research interests in the area of clinical trials and health services research.
As the Deputy Director of The George Institute for Global Health, Kazem leads the Healthcare Innovation and Evaluation programme, which aims to find practical and affordable solutions for the global health priorities of the world¹s largest emerging economies, as well as the priorities of vulnerable or disadvantaged populations in established economies.
Kazem graduated in medicine from the University of Leipzig in Germany with postgraduate training in cardiology, epidemiology, clinical trials and health services research in Leipzig, London and Oxford. Prior to joining the George Institute, in 2010, he was a Research Fellow at Oxford’s Clinical Trial Service and Epidemiological Studies Unit. His research interests include hypertension, heart failure and cardiovascular risk management, using a variety of methodologies such as individual-patient meta-analysis, large-scale complex intervention trials, and digital health technologies.
Kazem is currently the Chief Investigator of several large-scale projects and programmes including the SUPPORT-HF (a trial of remote self-management support in patients with heart failure), UNVEIL-CHF (a programme of research into variation in management of heart failure patients using large clinical datasets), BPLTTC (an international collaboration of blood pressure lowering trialists) and the SUPPORT-CVD trial (a large-scale cluster RCT of risk-stratified prevention and management of CVD with the use of low-cost technologies including the cardiovascular polypill).
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Mokdad AH. et al, (2016), The Lancet. Global health
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.
GBD 2015 HIV Collaborators None. et al, (2016), Lancet HIV, 3, e361 - e387
Blood pressure lowering for cardiovascular disease - Authors' reply.
Ettehad D. et al, (2016), Lancet (London, England), 388, 126 - 127
Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults.
Emdin CA. et al, (2016), International journal of epidemiology
Nonlinear Exposure-Outcome Associations and Public Health Policy.
Kiran A. et al, (2016), JAMA, 315, 1287 - 1288